Joen is the CEO of Hemcheck since May 2019. He previously worked as a management consultant at McKinsey & Company and Qvartz, where he mainly worked with the development of private and public healthcare organizations, both in Sweden and internationally. He holds a MSc from the Stockholm School of Economics. Joen Averstad owns 1,200,000 warrants and 35,211 shares in Hemcheck.
Peter is head of sales and marketing, and deputy CEO, at HemCheck since 2018. He previously worked as a Country Manager at M Care AB and between 1993-2018 he worked as General Manager for Sarstedt AB, where he focused on products and instruments within laboratory medicine. Peter has a master’s degree in economy with a specialization in marketing and organization from the Gothenburg School of Economics. Peter Andersson owns 120,000 warrants in Hemcheck.
Robert is the CFO of HemCheck since 2016. Robert has a master's degree in economy and extensive experience working with small and mid-sized public companies. Robert has previously worked as a consultant for KPMG and as the CFO at Aker Solutions.
David is the CTO of Hemcheck since 2021 and is responsible for product development at the company. Before David started at Hemcheck he was Director of Product Development at SciBase where he spent over 8 years. Before that, he has had several assignments and positions within product development, e.g. at Syntronic R&D AB.
Michael has been working with quality assurance at Hemcheck since 2021. He has long experience in the field of quality assurance in medtech and the food industry both as employee and consultant. He has for example worked as QA responsible at Bio-Rad, Barilla as well as a consultant at Sigma Industry East / North.